Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed.
Lewis NL, Scher R, Gallo JM, Engstrom PF, Szarka CE, Litwin S, Adams AL, Kilpatrick D, Brady D, Weiner LM, Meropol NJ.
Lewis NL, et al. Among authors: engstrom pf.
Cancer Chemother Pharmacol. 2002 Oct;50(4):257-65. doi: 10.1007/s00280-002-0500-0. Epub 2002 Aug 21.
Cancer Chemother Pharmacol. 2002.
PMID: 12357298
Clinical Trial.